Literature DB >> 2410982

Intrinsic and extrinsic factors in protein antigenic structure.

J A Berzofsky.   

Abstract

Recent advances in the preparation of synthetic peptide vaccines and the use of synthetic peptides as probes of antigenic structure and function have led to renewed interest in the prediction of antigenic sites recognized by antibodies and T cells. This review focuses on antibodies. Features intrinsic to the antigen, such as hydrophilicity and mobility, may be useful in the selection of amino acid sequences of the native protein that will elicit antibodies cross-reacting with peptides, or sequences which, as peptides, will be more likely to elicit antibodies cross-reactive with the native protein. Structural mobility may also contribute to protein-protein interactions in general. However, the entire accessible surface of a protein is likely to be detectable by a large enough panel of antibodies. Which of these antibodies are made in any individual depends on factors extrinsic to the antigen molecule, host factors such as self-tolerance, immune response genes, idiotype networks, and the immunoglobulin structural gene repertoire.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2410982     DOI: 10.1126/science.2410982

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  98 in total

1.  B-cell responses to a peptide epitope: mutations in heavy chain alone lead to maturation of antibody responses.

Authors:  R Tuteja
Journal:  Immunology       Date:  1999-05       Impact factor: 7.397

Review 2.  Methods of epitope mapping.

Authors:  I Pettersson
Journal:  Mol Biol Rep       Date:  1992-06       Impact factor: 2.316

Review 3.  Protein antigenicity.

Authors:  M H Van Regenmortel
Journal:  Mol Biol Rep       Date:  1992-06       Impact factor: 2.316

4.  Protein dynamics and the immunological evolution of molecular recognition.

Authors:  Ralph Jimenez; Georgina Salazar; Jun Yin; Taiha Joo; Floyd E Romesberg
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-04       Impact factor: 11.205

5.  Modeling the three-dimensional structures of an unbound single-chain variable fragment (scFv) and its hypothetical complex with a Corynespora cassiicola toxin, cassiicolin.

Authors:  Adeel Malik; Ahmad Firoz; Vivekanand Jha; Elumalai Sunderasan; Shandar Ahmad
Journal:  J Mol Model       Date:  2010-03-16       Impact factor: 1.810

6.  Protein-protein interactions with the acidic COOH terminus of the single-stranded DNA-binding protein of the bacteriophage T4.

Authors:  K B Krassa; L S Green; L Gold
Journal:  Proc Natl Acad Sci U S A       Date:  1991-05-01       Impact factor: 11.205

7.  Immunoaccessible peptide sequences of the major outer membrane protein from Chlamydia trachomatis serovar C.

Authors:  G M Zhong; R C Brunham
Journal:  Infect Immun       Date:  1990-10       Impact factor: 3.441

8.  Antibody evolution constrains conformational heterogeneity by tailoring protein dynamics.

Authors:  Jörg Zimmermann; Erin L Oakman; Ian F Thorpe; Xinghua Shi; Paul Abbyad; Charles L Brooks; Steven G Boxer; Floyd E Romesberg
Journal:  Proc Natl Acad Sci U S A       Date:  2006-09-05       Impact factor: 11.205

9.  Immunogenicity of membrane-bound HIV-1 gp41 membrane-proximal external region (MPER) segments is dominated by residue accessibility and modulated by stereochemistry.

Authors:  Mikyung Kim; Likai Song; James Moon; Zhen-Yu J Sun; Anna Bershteyn; Melissa Hanson; Derek Cain; Selasie Goka; Garnett Kelsoe; Gerhard Wagner; Darrell Irvine; Ellis L Reinherz
Journal:  J Biol Chem       Date:  2013-09-18       Impact factor: 5.157

10.  Closing and Opening Holes in the Glycan Shield of HIV-1 Envelope Glycoprotein SOSIP Trimers Can Redirect the Neutralizing Antibody Response to the Newly Unmasked Epitopes.

Authors:  Rajesh P Ringe; Pavel Pugach; Christopher A Cottrell; Celia C LaBranche; Gemma E Seabright; Thomas J Ketas; Gabriel Ozorowski; Sonu Kumar; Anna Schorcht; Marit J van Gils; Max Crispin; David C Montefiori; Ian A Wilson; Andrew B Ward; Rogier W Sanders; P J Klasse; John P Moore
Journal:  J Virol       Date:  2019-02-05       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.